Literature DB >> 20304818

Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.

Giuseppe Rengo1, Dario Leosco, Carmela Zincarelli, Massimo Marchese, Graziamaria Corbi, Daniela Liccardo, Amelia Filippelli, Nicola Ferrara, Michael P Lisanti, Walter J Koch, Anastasios Lymperopoulos.   

Abstract

Exercise training has been reported to exert beneficial effects on cardiac function and to reduce morbidity and mortality of chronic heart failure (HF). Augmented sympathetic nervous system (SNS) activity, leading to elevated circulating catecholamine (CA) levels, is a hallmark of chronic HF that significantly aggravates this disease. Exercise training has been shown to also reduce SNS overactivity in HF, but the underlying molecular mechanism(s) remain unidentified. We recently reported that adrenal G protein-coupled receptor kinase-2 (GRK2), an enzyme that regulates the sympathoinhibitory alpha(2)-adrenoceptors (alpha(2)-ARs) present in the CA-producing adrenal medulla, is upregulated in HF, contributing to the chronically elevated CA levels and SNS activity of the disease. In the present study, we tested whether exercise training can affect the adrenal GRK2-alpha(2)-AR-CA production system in the context of HF. For this purpose, a 10-wk-long exercise training regimen of adult male Sprague-Dawley rats starting at 4 wk postmyocardial infarction (post-MI) was employed, and examination at the end of this treatment period revealed significant amelioration of beta-AR-stimulated contractility in response to exercise training, accompanied by cardiac GRK2 reduction and restoration of circulating plasma CA levels. Importantly, adrenal GRK2 expression (72 + or - 5% reduction vs. post-MI untrained) and alpha(2)-AR number were also restored after exercise training in post-MI animals. These results suggest that exercise training restores the adrenal GRK2-alpha(2)-AR-CA production axis, and this might be part of the mechanism whereby this therapeutic modality normalizes sympathetic overdrive and impedes worsening of the failing heart.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304818     DOI: 10.1152/ajpheart.00702.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

2.  Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.

Authors:  G Rengo; C Zincarelli; G D Femminella; D Liccardo; G Pagano; C de Lucia; G G Altobelli; V Cimini; D Ruggiero; P Perrone-Filardi; E Gao; N Ferrara; A Lymperopoulos; W J Koch; D Leosco
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.

Authors:  G Rengo; A Lymperopoulos; C Zincarelli; Gd Femminella; D Liccardo; G Pagano; C de Lucia; A Cannavo; P Gargiulo; N Ferrara; P Perrone Filardi; Wj Koch; D Leosco
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 4.  G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.

Authors:  Stephen L Belmonte; Burns C Blaxall
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

Review 5.  GRK2 as a novel gene therapy target in heart failure.

Authors:  Giuseppe Rengo; Anastasios Lymperopoulos; Dario Leosco; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2010-08-25       Impact factor: 5.000

6.  Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function.

Authors:  Francesco Giallauria; Wanda Acampa; Francesca Ricci; Alessandra Vitelli; Giorgio Torella; Rosa Lucci; Giuseppina Del Prete; Emilia Zampella; Roberta Assante; Giuseppe Rengo; Dario Leosco; Alberto Cuocolo; Carlo Vigorito
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-06       Impact factor: 9.236

Review 7.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 8.  Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure.

Authors:  Katie A McCrink; Ava Brill; Anastasios Lymperopoulos
Journal:  World J Cardiol       Date:  2015-09-26

9.  Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats.

Authors:  Wenjuan Xing; Youyou Li; Haifeng Zhang; Chunjuan Mi; Zuoxu Hou; Michael J Quon; Feng Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

10.  β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.

Authors:  Alessandro Cannavo; Daniela Liccardo; Anastasios Lymperopoulos; Giuseppina Gambino; Maria Loreta D'Amico; Franco Rengo; Walter J Koch; Dario Leosco; Nicola Ferrara; Giuseppe Rengo
Journal:  J Pharmacol Exp Ther       Date:  2015-11-24       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.